Sleeping with the Enemy: How Intracellular Pathogens Cope with a Macrophage Lifestyle

article has not abstract

Published in the journal: . PLoS Pathog 8(3): e32767. doi:10.1371/journal.ppat.1002551
Category: Pearls
doi: 10.1371/journal.ppat.1002551


article has not abstract


Intracellular pathogens are a major cause of global morbidity and mortality. While this alone establishes their medical importance, they are also a focus of special interest because of their unique lifestyles. Many of these organisms have evolved to reside within the hostile environment of macrophages. Given that these innate immune effector cells are normally programmed to destroy ingested prey and promote the development of adaptive immunity, this is one of the ultimate paradoxes in the study of host–pathogen interactions. The success of these microbes is dependent on diverse strategies including the disruption of macrophage cell regulation, the ability to nullify macrophage microbicidal effector mechanisms, and other special adaptations to an intracellular lifestyle. Here, we review a series of well established survival paradigms that have emerged that illustrate this behaviour.

Targeting Critical Signaling Pathways Prevents Effective Macrophage Activation and Promotes Survival of Intracellular Pathogens

Activated macrophages form a heterogeneous collection of cells with functions as diverse as secretion of pro- or anti-inflammatory mediators, intracellular pathogen killing, induction of T-helper 1 or T-helper 2 cell responses, extracellular matrix synthesis and tissue repair, and others. Not surprisingly, many intracellular microbes interfere with host cell signaling in order to prevent or modulate cellular activation in their favour.

One notable example involves interference with host protein kinase and phosphatase activities, thereby preventing macrophage activation. Leishmania release effectors that activate macrophage phosphotyrosine phosphatases, leading to inhibition of Jak-STAT and mitogen-activated protein (MAP) kinase signaling [1] (and see also supplemental references [S1,S2,S3] in Text S1). The Leishmania surface lipophosphoglycan (LPG) [2] and Mycobacterium tuberculosis (Mtb) protein kinase G [3] both suppress protein kinase C activity, thereby inhibiting the macrophage oxidative burst in response to Leishmania [S4] and attenuating phagocytosis of Mtb [3]. Activation of PI3K has been observed during infection with Mtb [S5], Francisella tularensis [4], and Leishmania [5,S6], leading to inhibition of both apoptosis and pro-inflammatory cytokine secretion with reciprocal enhancement of anti-inflammatory cytokine production. Furthermore, pathogens such as Leishmania amazonensis and Mtb modulate host protein synthesis through effects on protein kinase R, or interference with Toll-like receptor (TLR)-mediated activation of the transcription factor NFκB [S7,S8].

Intracellular microbes can shape macrophage phenotypes by modulating cytokine secretion, which determines the fate of the downstream host response. Most pathogens inhibit production of pro-inflammatory cytokines such as IL-12, TNF-α, and IFN-γ, and induce production of anti-inflammatory cytokines such as IL-10, TGF-β, and IL-4, thereby down-regulating immunopathology and host defence mechanisms. Importantly, signaling pathways centered on IFN-γ, the predominant inducer of macrophage-mediated microbicidal functions, are commonly targeted by intracellular pathogens. Down-regulation of IFN-γ receptor expression or interference with the IFN-γ receptor downstream effectors Jak and STAT have been observed during infection with Mtb [S9,S10], Trypanosoma cruzi [S11], and Leishmania [S2,S12].

Prolonged survival in macrophages also requires prevention of adaptive immunity. To this end, Mtb inhibits expression of the class II transactivator and MHC class II molecules and antigen presentation, thereby evading effective recognition by CD4+ T cells (for a review see [6]). Similar phenomena have been observed during infection with Toxoplasma gondii [S13], Leishmania [S14,S15], and Salmonella [S16].

Coping with an Intracellular Lifestyle May Involve Escaping from the Phagosome, Modulating Phagosome Maturation, or Liaisons with Autophagosomes

Phagocytic uptake of pathogens by macrophages results in the formation of vacuoles that, by interactions with vesicles of the endosomal system, are intended to transform into microbicidal phagolysosomes through a process known as phagosome maturation. Intracellular pathogens residing within phagosomes, however, have evolved mechanisms to either subvert or delay the maturation process, or to escape from their vacuoles altogether.

Organisms such as Mtb and Salmonella block maturation by targeting key regulatory pathways including PI 3-kinase signalling and small GTPase Rab conversions, which ordinarily promote the acquisition and activation of effectors needed for maturation to occur. Both Mtb [7,S17,S18] and Salmonella enterica typhimurium [S19,S20] secrete phosphoinositide phosphatases that dephosphorylate phosphoinositides on the phagosome membrane. Mtb [S21–S25] and S. typhimurium [S26,S27] also actively prevent the acquisition and activation of Rab7 and its downstream effectors. Similarly, S. typhimurium interferes with Rab9 recruitment to the Salmonella-containing vacuole [S28]. In addition, Mtb secretes protein tyrosine phosphatase A, which interferes with late endosome/lysosome vesicular interactions [8], and its cell wall lipid ManLAM modulates MAP kinase signaling, leading to phagosome maturation arrest between early and late stages [S29,S30].

Other pathogens such as Legionella pneumophila [S31,S32], Leishmania [S33–S35], and Coxiella burnetti [S36–S38] do not arrest, but rather delay, phagosome maturation in order to provide time to switch from an extracellular form to one that is able to cope with conditions in a phagolysosome [9]. Leishmania delay maturation using their surface-associated lipophosphoglycan, during which time these protozoan parasites switch from the promastigote form to the phagolysosome-resistant amastigote form [S39]. Legionella [S40] and Coxiella secrete effectors via their Type IV secretion system that aid in delaying phagosome maturation. In addition, Legionella surface composition and the secretion of microvesicles delay maturation independent of Type IV secretion [S41].

Interestingly, intracellular pathogens not only adapt to resist the harsh conditions in the phagolysosome, but may actually require lysosomal as well as autophagosomal interactions to facilitate the delivery of nutrients [10,S42–S45]. Autophagy is a mechanism whereby cells recycle cellular components by enclosing them in autophagosomes that fuse with lysosomes to mediate degradation of their contents. Although autophagy plays a role in host defence by encapsulating and degrading microbes, this pathway is also important in facilitating survival of Chlamydia [S46], Brucella abortus [S47], and Yersinia [S48,S49].

Not all pathogens that enter the host cell in a phagosome remain there. Listeria monocytogenes [S50,S51] and Shigella flexneri [S52,S53] escape from phagosomes by forming actin tails. This enables them to move within the infected cell, preventing their recognition and killing by autophagy and allowing dissemination to neighbouring cells [11]. Unlike L. monocytogenes and S. flexneri, which leave their phagosomes at an early stage of phagosome maturation, the protozoan T. cruzi escapes from its vacuole after lysosomal fusion, when low pH conditions favour hemolysin activity [S54,S55].

Acquisition of Essential Nutrients and Co-Factors from Host Cells Promotes Growth and Replication of Intracellular Pathogens

In order to survive and replicate within their host cells, microbes must gain access to nutrients. Pathogens such as L. monocytogenes and S. flexnerii escape from phagosomes into the cytosol, which is relatively nutrient-rich. In contrast, persistent phagosome dwellers face restrictive conditions for access to metal cations such as Fe2+, Mn2+, and Co2+, as these are transported out of the phagosome via the Nramp (natural resistance–associated macrophage protein) transporter [12,S56]. To compete against Nramp, certain bacteria express an Nramp homolog [S57,S58]. This allows them to acquire cation cofactors that are essential for bacterial reactive oxygen intermediate (ROI) detoxifying enzymes [13]. Since greater than 80% of total body iron is bound to heme, and iron is further sequestered by transferrin and lactoferrin, free iron is in short supply in host cells. This serves as an important mechanism of resistance against microbial invaders. To obtain iron, Leishmania express receptors that allow internalisation of hemoglobin, transferrin, and lactoferrin [14,S59,S60], and exploit the iron labile pool in macrophages [S61]. Bacterial pathogens express iron-chelating siderophores such as mycobacterial mycobactins [15], salmochelin released by Salmonella and Shigella [S62,S63], and Yersinia yersiniabactin [S64], all of which compete with transferrin or lactoferrin for iron. In conjunction with siderophore production, Mtb also express a heme uptake system [S65].

In addition to iron, pathogens whose niche is restricted to phagosomes must also acquire carbon. Mtb uses fatty acids and cholesterol as a carbon source and this is essential for persistence [16,S66,S67]. Salmonella uses host glucose, phosphorylated carbohydrates, and fatty acids as carbon sources [S68,S69]. Pathogens such as Leishmania [S42], Chlamydia [S46], and Coxiella [S44,S70,S43] also reside in phagolysosomes that intersect with autophagosomes that provide amino acids and other nutrients.

Strategies Used to Prevent or Resist the Phagocyte Oxidative Burst or the Formation of Reactive Nitrogen Intermediates

A major weapon in the macrophage antimicrobial arsenal is the phagocyte oxidative burst, which results in the generation of ROIs such as superoxide, hydrogen peroxide, and hypochlorous acid. The importance of the oxidative burst to host defence is illustrated by patients with chronic granulomatous disease who, due to oxidase mutations, cannot form ROIs and consequently suffer from recurrent bacterial and fungal diseases.

There are at least two strategies by which intracellular pathogens modulate the oxidative burst: (1) by preventing assembly of the macrophage NADPH oxidase that produces ROIs, or (2) by detoxifying ROIs as they are formed. The Salmonella pathogenicity island (SPI)-2, which encodes for a Type III secretion apparatus, is necessary for preventing NADPH oxidase assembly on the phagosome membrane [17,S71]. Leishmania also prevent NADPH oxidase assembly through surface LPG, which serves a dual role by also scavenging ROIs directly [S72,S35].

Apart from targeting NADPH assembly and activation, many pathogens express enzymes that neutralize ROIs. L. monocytogenes [S73], Salmonella [18], Yersinia [S74], F. tularensis [S75], and Mtb [S76,S77] all express surface-associated and cytoplasmic superoxide dismutases, which scavenge superoxide radicals. In addition, many of these pathogens also secrete catalase-peroxidase, which breaks down H2O2 [S78–S82].

The catalase-peroxidases of Salmonella and Mtb can also act as peroxynitritases that deactivate peroxynitrite formed when nitric oxide (produced by inducible nitric oxide synthase [iNOS]) reacts with superoxide [19,S80]. T. cruzi also deactivates peroxynitrite, which is critical for pathogen survival within the host macrophage [S83]. The expression of iNOS and production of reactive nitrogen intermediates (RNIs) is a critical macrophage microbicidal mechanism dependent upon the oxidation of L-arginine. iNOS activity competes for this amino acid with arginase 1, which promotes the production of urea. Mtb skews the balance by upregulating arginase expression via autocrine cytokine signaling in infected macrophages in order to curtail iNOS activity [20]. If RNIs are indeed formed, certain microorganisms have detoxification mechanisms to call upon, such as Salmonella factors secreted by Type III secretion [21], and the truncated hemoglobins of Mtb [S84], Mycobacterium bovis [S85], and Mycobacterium leprae [S86]. In parallel with detoxification of RNIs, Salmonella also repair nitrosative damage using flavohemoglobins [22], flavorubredoxin, and cytochrome C nitrite reductase [S87].

Manipulation of Macrophage Death Pathways Supports an Intracellular Lifestyle

When macrophages fail to eliminate infecting pathogens, programmed cell death is often initiated as a last resort to resolve the infection. Three major modes of cell death may occur in response to infection: apoptosis, necrosis, and pyroptosis. Apoptosis is characterised by retention of membrane integrity coupled with the formation of apoptotic bodies and is generally viewed as being immunologically silent. Apoptotic cells are engulfed by neighbouring phagocytes, which may result in pathogen degradation and initiation of adaptive immunity. In contrast, necrosis and pyroptosis trigger rapid inflammatory responses, as necrotic and pyroptotic cells secrete pro-inflammatory cytokines and release cytoplasmic contents extracellularly.

In order to retain their intracellular niche, many intracellular pathogens prevent host cell death. A major mechanism to inhibit apoptosis is interference with caspase signaling cascades. Inhibition of effector caspases 3 and 8 has been observed during infection with T. gondii [S88] and T. cruzi [S89]. Activation of caspase death cascades can also be subverted by preventing cytochrome C release from mitochondria, a strategy shared by T. gondii [S90] and Leishmania [S91]. Other pro-survival, host signaling cascades exploited by pathogens to confer resistance to apoptosis are activation of the PI3K/Akt axis by L. major and L. amazonensis [5] and T. gondii [23] and activation of NFκB by Ehrlichia chaffeensis [S92], L. monocytogenes [S93], and L. pneumophila [S94,S95]. Activation of these pathways results in the upregulation of pro-survival molecules of the Bcl-2 family, inhibition of cytochrome C release, and activation of inhibitor of apoptosis proteins (IAPs). Additional strategies to inhibit apoptosis include expression of orthologs of host anti-apoptotic molecules, such as macrophage migration inhibitory factor by L. major [S96], or induction of anti-apoptotic heat shock proteins by T. gondii [S97]. Prevention of pyroptotic cell death has been demonstrated for Yersinia enterocolitica and Mtb, brought about by inhibition of caspase-1 activation and inflammasome formation [24,S98].

Conversely, several pathogens induce cell death in order to promote dissemination, or to evade systemic immunity or both. Whereas intracellular pathogens generally avoid initiating pro-inflammatory necrosis or pyroptosis, initiation of macrophage apoptosis may benefit the pathogen by promoting dissemination to other macrophages without activating them and often reflects a productive infectious cycle. Initiation of macrophage apoptosis has been reported for T. cruzi [25], L. major, Leishmania aethiopica, and Leishmania tropica [26], and Yersinia pseudotuberculosis [27,S99]. The fact that both T. cruzi and Leishmania spp. have been shown to be capable of either preventing or inducing apoptosis at first blush appears paradoxical. It seems plausible, however, that these juxtaposed behaviours may reflect different stages of infection. Thus, prevention of apoptosis early after infection may allow for preservation of the intracellular niche and replication, whereas during late stage infection, induction of apoptosis facilitates pathogen release, dissemination, and silent uptake by other macrophages. This behaviour is also exhibited by virulent Mtb, which has been shown to prevent apoptosis, but induce necrosis of infected macrophages to promote the spread of bacilli [28,S100]. It has further been shown that T. gondii [S101], Leishmania donovani [S102], and M. bovis [S103] induce apoptosis of non-infected bystander cells to deplete monocytes, macrophages, and CD4+ and/or CD8+ T cells.

Concluding Remarks

Intracellular pathogens have evolved a wide and diverse range of strategies to avoid or defend against macrophage innate immune effector mechanisms. In response, macrophages are equipped with various countermeasures such as phosphorylating secreted microbial superoxide dismutases to inactivate them [29] and the production of host proteins that recognize and bind to microbial iron chelators, thereby preventing pathogen iron uptake [30,S104]. A deeper understanding of these macrophage countermeasures and their regulation, as well as how pathogens regulate their own responses to the macrophage environment, will prove to be fertile ground for developing targeted therapeutic strategies in years to come.

Supporting Information

Attachment 1


1. NandanDYiTLopezMLaiCReinerNE 2002 Leishmania EF-1alpha activates the Src homology 2 domain containing tyrosine phosphatase SHP-1 leading to macrophage deactivation. J Biol Chem 277 50190 50197

2. DescoteauxAMatlashewskiGTurcoSJ 1992 Inhibition of macrophage protein kinase C-mediated protein phosphorylation by Leishmania donovani lipophosphoglycan. J Immunol 149 3008 3015

3. ChaurasiyaSKSrivastavaKK 2009 Downregulation of protein kinase C-alpha enhances intracellular survival of Mycobacteria: role of PknG. BMC Microbiol 9 271

4. MedinaEAMorrisIRBertonMT 2010 Phosphatidylinositol 3-kinase activation attenuates the TLR2-mediated macrophage proinflammatory cytokine response to Francisella tularensis live vaccine strain. J Immunol 185 7562 7572

5. RuhlandALealNKimaPE 2007 Leishmania promastigotes activate PI3K/Akt signalling to confer host cell resistance to apoptosis. Cell Microbiol 9 84 96

6. HardingCVBoomWH 2010 Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors. Nat Rev Microbiol 8 296 307

7. VergneIChuaJLeeHHLucasMBelisleJ 2005 Mechanism of phagolysosome biogenesis block by viable Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 102 4033 4038

8. BachHPapavinasasundaramKGWongDHmamaZAv-GayY 2008 Mycobacterium tuberculosis virulence is mediated by PtpA dephosphorylation of human vacuolar protein sorting 33B. Cell Host Microbe 3 316 322

9. SwansonMSFernandez-MoreiraE 2002 A microbial strategy to multiply in macrophages: the pregnant pause. Traffic 3 170 177

10. AlexanderJVickermanK 1975 Fusion of host cell secondary lysosomes with the parasitophorous vacuoles of Leishmania mexicana-infected macrophages. J Protozool 22 502 508

11. YoshikawaYOgawaMHainTYoshidaMFukumatsuM 2009 Listeria monocytogenes ActA-mediated escape from autophagic recognition. Nat Cell Biol 11 1233 1240

12. VidalSMMaloDVoganKSkameneEGrosP 1993 Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell 73 469 485

13. AgranoffDMonahanIMManganJAButcherPDKrishnaS 1999 Mycobacterium tuberculosis expresses a novel pH-dependent divalent cation transporter belonging to the Nramp family. J Exp Med 190 717 724

14. VoyiatzakiCSSoteriadouKP 1992 Identification and isolation of the Leishmania transferrin receptor. J Biol Chem 267 9112 9117

15. De VossJJRutterKSchroederBGSuHZhuY 2000 The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages. Proc Natl Acad Sci U S A 97 1252 1257

16. McKinneyJDHoner zuBKMunoz-EliasEJMiczakAChenB 2000 Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 406 735 738

17. Vazquez-TorresAXuYJones-CarsonJHoldenDWLuciaSM 2000 Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase. Science 287 1655 1658

18. SlyLMGuineyDGReinerNE 2002 Salmonella enterica serovar Typhimurium periplasmic superoxide dismutases SodCI and SodCII are required for protection against the phagocyte oxidative burst. Infect Immun 70 5312 5315

19. WengenackNLJensenMPRusnakFSternMK 1999 Mycobacterium tuberculosis KatG is a peroxynitritase. Biochem Biophys Res Commun 256 485 487

20. QuallsJENealeGSmithAMKooMSDeFreitasAA 2010 Arginine usage in mycobacteria-infected macrophages depends on autocrine-paracrine cytokine signaling. Sci Signal 3 ra62

21. ChakravorttyDHansen-WesterIHenselM 2002 Salmonella pathogenicity island 2 mediates protection of intracellular Salmonella from reactive nitrogen intermediates. J Exp Med 195 1155 1166

22. CrawfordMJGoldbergDE 1998 Role for the Salmonella flavohemoglobin in protection from nitric oxide. J Biol Chem 273 12543 12547

23. KimLDenkersEY 2006 Toxoplasma gondii triggers Gi-dependent PI 3-kinase signaling required for inhibition of host cell apoptosis. J Cell Sci 119 2119 2126

24. MasterSSRampiniSKDavisASKellerCEhlersS 2008 Mycobacterium tuberculosis prevents inflammasome activation. Cell Host Microbe 3 224 232

25. Freire-de-LimaCGNunesMPCorte-RealSSoaresMPPreviatoJO 1998 Proapoptotic activity of a Trypanosoma cruzi ceramide-containing glycolipid turned on in host macrophages by IFN-gamma. J Immunol 161 4909 4916

26. GettiGTChekeRAHumberDP 2008 Induction of apoptosis in host cells: a survival mechanism for Leishmania parasites? Parasitology 135 1391 1399

27. MonackDMMecsasJGhoriNFalkowS 1997 Yersinia signals macrophages to undergo apoptosis and YopJ is necessary for this cell death. Proc Natl Acad Sci U S A 94 10385 10390

28. ChenMGanHRemoldHG 2006 A mechanism of virulence: virulent Mycobacterium tuberculosis strain H37Rv, but not attenuated H37Ra, causes significant mitochondrial inner membrane disruption in macrophages leading to necrosis. J Immunol 176 3707 3716

29. ArchambaudCNahoriMAPizarro-CerdaJCossartPDussurgetO 2006 Control of Listeria superoxide dismutase by phosphorylation. J Biol Chem 281 31812 31822

30. JohnsonEESrikanthCVSandgrenAHarringtonLTrebickaE 2010 Siderocalin inhibits the intracellular replication of Mycobacterium tuberculosis in macrophages. FEMS Immunol Med Microbiol 58 138 145

Hygiena a epidemiologie Infekční lékařství Laboratoř

Článek vyšel v časopise

PLOS Pathogens

2012 Číslo 3

Nejčtenější v tomto čísle

Tomuto tématu se dále věnují…


Zvyšte si kvalifikaci online z pohodlí domova

Cesta pacienta s CHOPN
nový kurz
Autoři: doc. MUDr. Vladimír Koblížek, Ph.D.

Arteriální hypertenze ve světle nových evropských guidelines
Autoři: MUDr. Libor Jelínek

Precizní medicína v onkologii

Kožní toxicita cílené terapie inhibitory EGFR a VEGF
Autoři: MUDr. Karolína Svobodová

Jak na psoriázu v každodenní ambulantní praxi?
Autoři: MUDr. Jan Šternberský, Ph. D.

Všechny kurzy
Kurzy Doporučená témata Časopisy
Zapomenuté heslo

Nemáte účet?  Registrujte se

Zapomenuté heslo

Zadejte e-mailovou adresu se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.


Nemáte účet?  Registrujte se